The decreases in pSyk activation by CD38 receptor inhibition are consistent with previous studies where CD31 stimulation increased pSyk levels in CLL cells16; conversely, DARA treatment decreased pSyk activation upon BCR stimulation.39 Here, BCR is linked to B-cell chronic lymphocytic leukemia.